Rheumnow Podcast-logo

Rheumnow Podcast

Health & Wellness Podcasts

Here and now

Here and now

Location:

United States

Description:

Here and now

Language:

English

Contact:

6822290477


Episodes

Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS–Sponsored by AbbVie Medical Affairs

9/30/2022
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Great And Not - So Great (9.30.2022)

9/30/2022
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.

Heavy Metal Rheumatology (9.23.2022)

9/23/2022
Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.

Duration:00:28:25

CD19 CAR T Cell Therapy In SLE (9.16.2022)

9/16/2022
Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com

Duration:00:19:20

Does Fibromyalgia Need B12

9/9/2022
Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if Sjogens will develop lymphoma? Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com

Duration:00:27:04

StillsNow Podcast August 2022 - Genetic Testing for Autoinflammatory Diseases

9/6/2022
Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital

Duration:00:28:27

Goofy But True (9.2.2022)

9/2/2022
Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

Duration:00:22:51

Rainbow Rheumatology (8.26.2022)

8/26/2022
Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com “Climate is what we expect, weather is what we get.” – Mark Twain

Duration:00:21:19

Managing JDM With Calcinosis (8.19.2022)

8/19/2022
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.

Duration:00:27:53

Hit Parade Review (8.12.2022)

8/12/2022
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.

Duration:00:19:30

The Great Unknowns (8.5.2022)

8/5/2022
Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

Duration:00:28:45

QD Clinics - Still's Or Not - Part 2

7/29/2022
QD197 - Still's (or Not) NEJM CPC https://youtu.be/_xnCaxeqidw QD198 - Still's (or Not) with Daily Fevers https://youtu.be/J1bezuA-f_s QD199 - Still's (or Not): an FUO Evaluation https://youtu.be/0qDijCAqEpQ QD200 - Still's (or Not): Fever, Joint pain & Itchy Eyes https://youtu.be/utvFA1lx1lc

Duration:00:27:26

Social Media Questions (7.29.2022)

7/29/2022
Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.

Duration:00:25:28

TNR Still's Now Journal Club - Pivotal Trials in SJIA & AOSD Approved Meds

7/27/2022
This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes: - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 https://bit.ly/3coPFg0 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q

Duration:00:58:51

Early, Aggressive & Seropositive (7.22.2022)

7/22/2022
Early, Aggressive & Seropositive (7.22.2022) by Dr. Cush

Duration:00:18:03

Copy of TNR- Still's Now Journal Club - Seminal Articles from 1971 & 1973

7/20/2022
Join Dr. Michael Weisman, Dr. Bella Mehta and Dr. Jack Cush in this live, one-hour Journal Club to discuss: 1. Still's disease in the adult. EGL Bywaters. Annals of Rheumatic Disease 1971 2. Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. J Bujak, et al. Medicine 1973

Duration:00:58:57

Fever Pitch (7.15.2022)

7/15/2022
Dr. Jack Cush reviews the new studies and drug approvals and new insights into febrile disorders from the past week on RheumNow.com

Duration:00:19:53

QD Clinics - Still's Or Not - Part 1

7/15/2022
QD193 - Stills (or Not) MAS off of Tocilizumab https://youtu.be/xIco2Xdxf68 QD194 - Stills (or Not) with Widespread Pain https://youtu.be/50BXYafkVZM QD 195 - Stills (or Not) with Hives https://youtu.be/f4tPMylrnpQ QD 196 - Stills (or Not); A Wifes Letter https://youtu.be/eRnisH0Hjhw

Duration:00:27:52

ICYMI 2021 Rheumatology Year In Review

7/8/2022
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors https://rheumnow.com/news/2021-rheumatology-year-review-172022

Duration:00:25:32

Solving Stills Disease

7/1/2022
Still's disease is the most common rheumatic cause of unknown fever in adults. This series by Dr. Jack Cush covers the definition, history, epidemiology, key manifestations and labs, diagnostic criteria, pathogenesis and the management of adult-onset Still's disease. Dr. Cush is the executive editor of StillsNow.com - a new medical education site focused on Still's disease and other febrile autoinflammatory disorders. You can subscribe to the website's monthly email with updated social...

Duration:00:46:55